Kiran Mazumdar-Shaw Rejects Buyout Bids to Focus on Biocon’s Long-Term Independence
Strategic Independence Over Short-Term Gains Kiran Mazumdar-Shaw, the executive chairperson of Biocon, confirmed this week that she has consistently rejected multiple high-value acquisition offers for both Biocon and its research arm, Syngene International. Speaking at a recent corporate forum, the billionaire entrepreneur emphasized that her primary objective remains the cultivation of a sustainable, global enterprise…
